Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Treasury Shares: 2020-2024

  • KalVista Pharmaceuticals' Treasury Shares was N/A to $626,272 in Q2 2024 from the same period last year, while for Apr 2024 it was $626,272, marking a year-over-year change of. This contributed to the annual value of $626,272 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q2 2024, KalVista Pharmaceuticals' Treasury Shares is $626,272, which was up 1,291.72% from $45,000 recorded in Q2 2020.
  • KalVista Pharmaceuticals' Treasury Shares' 5-year high stood at $626,272 during Q2 2024, with a 5-year trough of $45,000 in Q2 2020.
  • Moreover, its 1-year median value for Treasury Shares was $626,272 (2024), whereas its average is $626,272.